Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Fc receptor-like 1 (FCRL1) is a novel biomarker for prognosis and a possible therapeutic target in diffuse large B-cell lymphoma

Published:2022-11-21 Issue:2 Volume:50 Page:1133-1145
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Yousefi Zahra,Sharifzadeh Sedigheh,Zare Farahnaz,Eskandari Nahid

Funder

Isfahan University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-08104-7.pdf

Reference51 articles.

1. Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ (2018) Non-Hodgkin lymphoma. BMJ (Clin Res ed) 362:k3204. https://doi.org/10.1136/bmj.k3204

2. Susanibar-Adaniya S, Barta SK (2021) 2021 Update on Diffuse large B cell lymphoma: a review of current data and potential applications on risk stratification and management. Am J Hematol 96:617–629. https://doi.org/10.1002/ajh.26151

3. Chen B-J, Fend F, Campo E, Quintanilla-Martinez L (2019) Aggressive B-cell lymphomas: from morphology to molecular pathogenesis. Ann Lymphoma. https://doi.org/10.21037/aol.2018.12.02

4. Frick M, Dörken B, Lenz G (2011) The molecular biology of diffuse large B-cell lymphoma. Ther Adv Hematol 2:369–379. https://doi.org/10.1177/2040620711419001

5. Weber T, Schmitz R (2022) Molecular subgroups of diffuse large B cell lymphoma: biology and implications for clinical practice. Curr Oncol Rep 24:13–21. https://doi.org/10.1007/s11912-021-01155-2

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell clonality in cancer;Seminars in Immunology;2024-03

2. Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review;Brain, Behavior, & Immunity - Health;2024-03

3. Natural killer cell‐based signature: Prognostic analysis in head and neck squamous cell carcinoma;The Journal of Gene Medicine;2024-02

4. Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsies;Frontiers in Oncology;2023-10-25

5. FCRL1 immunoregulation in B cell development and malignancy;Frontiers in Immunology;2023-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3